340B Report

House GOP Bill Would Stop Additional Hospitals and Child Sites from 340B Enrollment and Make it Harder for Current Hospitals to Remain Eligible

In Federal, LegislativeJanuary 24, 20231343 Views

U.S. Rep. Matt Rosendale (R-Mont.) has reintroduced a bill to put a moratorium on 340B hospital growth, impose 340B reporting requirements on hospitals, and make it harder for private nonprofit hospitals to stay in 340B.

A new U.S. House bill would put a moratorium on 340B hospital growth and impose a host of reporting requirements on 340B hospitals. It would also make it much harder for private nonprofit hospitals to remain in the

…

U.S. House Leaders Agree on Committee Ratios: Energy & Commerce Gets to Work

In Federal, LegislativeJanuary 24, 2023181 Views

Ted Slafsky and Tom Mirga

The composition of the House Energy & Commerce Committee in this Congress is clear now that party leaders have agreed on committee sizes and ratios.

U.S. House Speaker Kevin McCarthy (R-Calif.) and Minority Leader Hakeem Jeffries (D-N.Y.) have reached an agreement on the balance of power in committees during this Congress and are expected to formally assign members to committees as soon as

…

The Top 5 Marketing Tips for Building Your Patient Base

In Sponsored ContentJanuary 24, 2023147 Views

Astellas Notifies 340B Entities About Antifungal’s Updated NDC

In Federal, Pharma Industry, RegulatoryJanuary 24, 2023164 Views

Tom Mirga

Astellas says the old and new NDCs for its antifungal drug Cresemba are interchangeable in compliant 340B inventory replenishment models.

Drug manufacturer Astellas will let 340B covered entities using “a compliant 340B inventory replenishment model” count accumulations of its antifungal Cresemba under its old National Drug Code toward replenishment of equal quantities under the product’s corresponding new NDC,

…

End 340B, Commentary in New England Journal of Medicine Suggests

In Research/ReportsJanuary 20, 2023597 Views

Tom Mirga

Policymakers should consider disbanding the 340B program, a student and a professor at the Stanford University School of Medicine say in the New England Journal of Medicine.

Policymakers should consider disbanding the 340B program “given its negative reverberations for patients and markets,” a student and a professor at the Stanford University School of Medicine wrote in a commentary in the latest edition of the New

…

MedPAC Votes to Recommend Ditching Medicare DSH Patient Percentage for Medicare Purposes

In Federal, LegislativeJanuary 20, 2023241 Views

Tom Mirga

MedPAC thinks CMS should stop using the Medicare DSH patient percentage for Medicare purposes. The 340B program uses the DSH calculation for hospital eligibility purposes.

The Medicare Payment Advisory Commission, as expected, has voted to recommend that Congress should start phasing in a new way of distributing extra Medicare payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.

The

…

The Mpox Outbreak: What a Swift Response Looks Like

In Sponsored ContentJanuary 20, 2023234 Views

Ryan White Clinics for 340B Access Is Dropping its 340B Dispute Resolution Lawsuit

In Federal, JudicialJanuary 20, 2023249 Views

Tom Mirga

RWC-340B is dropping is lawsuit that helped prod HRSA to issue long-delayed 340B dispute resolution rules.

Ryan White Clinics for 340B Access is dropping its lawsuit that, together with a related case, led federal health officials to issue long-delayed dispute resolution rules for the 340B program in December 2020.

RWC-340B, five co-plaintiff 340B covered

…

Pennsylvania Rescinds Directive that Contract Pharmacies May Not Dispense 340B Drugs to Medicaid Beneficiaries

In Regulatory, StateJanuary 20, 2023569 Views

Tom Mirga

Pennsylvania rescinded a new Medicaid policy document that said contract pharmacies could not dispense 340B-purchased drugs to Medicaid beneficiaries.

The Pennsylvania Department of Human Services yesterday rescinded Medicaid policy guidance dated Dec. 22 and effective Jan. 1 that forbade 340B covered entities’ contract pharmacies from dispensing 340B-purchased drugs to Medicaid beneficiaries.

The state primary care association warned

…

Oregon Bill Targets PBM Policies that Discriminate Against 340B Pharmacies

In Legislative, PBMs and Payers, StateJanuary 20, 2023213 Views

Laura Gilcrest

A bill in Oregon would prohibit discriminatory practices by PBMs and insurance plans against 340B pharmacies.

Oregon legislators have introduced a bill that would prohibit discriminatory practices by pharmacy benefit managers and insurance plans against 340B pharmacies, including reimbursing a 340B pharmacy less for prescription drugs compared with non-340B pharmacies.

If passed later this

…

Blog Posts